EP 1058B - Increase in Hep A Cases: So, Travel Smart. What YOU Need to Know Aortic Condition More Deadly in Women than Men

The Centers for Disease Control (CDC) recently issued a report showing a more than 1,300% increase in hepatitis A infections between 2015-2019. On the heels of the CDC report is AAA’s announcement that from May 27 through May 31 more than 37 million people are expected to travel 50 miles or more from home, an increase of 60% from last year. With summer travel about to swing into high gear, a piece discussing what travelers need to know about Hepatitis A and how to protect themselves before hitting the road.

Hepatitis A is a vaccine-preventable liver disease caused by the hepatitis A virus (HAV). HAV is usually transmitted person-to-person through the fecal–oral route or through consumption of contaminated food or water. The majority of adults and older children with hepatitis

Signs and symptoms associated with hepatitis A can include the following: fever, fatigue, nausea, vomiting, loss of appetite, abdominal pain, dark urine, and clay-colored stools. Hepatitis A is a self-limited disease that does not result in chronic infection. The best way to prevent hepatitis A is by being vaccinated.

Dr. Robert Gish will tell us all about Hepatitis strains and their vaccines. Dr. Gish is an Adjunct Professor of Medicine at the University of Nevada School of Medicine in Las Vegas, a Clinical Professor at the University of Nevada Reno School of Medicine, and a Clinical Professor at the University of California Skaggs School of Pharmacy and Pharmaceutical Sciences. In addition, he is also the Medical Director of the Hepatitis B Foundation and Medical Director of the Asian Pacific Health Foundation.


Want better health and nutrition? Now you can get personalized supplement recommendations and custom vitamin packs delivered to your door! Go to PersonaNutrition.com/Roizen and take your free assessment and get 50% off your order today. 
- sponsor



Persona logo


 

Bonus
How Your Diet Affects Your Risk for Cancer



EP 1058B - Increase in Hep A Cases:  So, Travel Smart. What YOU Need to Know Aortic Condition More Deadly in Women than Men
Featuring:
Dr. Robert Gish
Dr. Robert Gish is a fellow of the FAASLD, AST, and American College of Physicians. He was a major early contributor to decipher methods for the detection of hepatitis B and C virus and characterizing their epidemiology and clinical presentation in humans. He is also Medical Director of the Asia Pacific Health Foundation and of the Hepatitis B Foundation.